EASThigh-AFNET 11 is a prospective, randomized, multicenter treatment strategy trial evaluating the effectiveness and safety of early atrial fibrillation ablation with the Cryoballoon compared to usual care in patients with atrial fibrillation and a high comorbidity burden (CHA2DS2-VASc score ≥ 4).